Briefing Chat: How Dolly Parton left her mark on science
About this episode
This episode celebrates Dolly Parton's contributions to science and discusses a promising melanoma vaccine trial.
In this episode: 00:18 Researchers celebrate Dolly Parton's contributions to science Nature: Dolly Parton dies aged 80 — researchers celebrate her contributions to science 08:40 Phase III trial of melanoma vaccine shows promise Nature: Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments? Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday. Hosted on Acast. See acast.com/privacy for more information.
More episodes of Nature Podcast
- Briefing Chat: The Bunsen burner myth that turns out to be just hot air
- Phone tutoring boosts math scores when schools are forced to close
- Briefing Chat: How 1,000 pairs of buried underpants helped measure soil health
- Audio long read: Could mending damaged DNA prolong life?
- Highest-ever ocean temperatures recorded as El Niño intensifies
- Briefing Chat: New narcolepsy drug could unlock host of novel brain therapies
Explore listener stats, chart rankings, contacts and more on the Nature Podcast podcast page.